| Autor: |
Barron MR; Department of Microbiology & Immunology, University of Michigan Medical Schoolgrid.471406.0, Ann Arbor, Michigan, USA., Sovacool KL; Department of Computational Medicine & Bioinformatics, University of Michigan Medical Schoolgrid.471406.0, Ann Arbor Michigan, USA., Abernathy-Close L; Division of Rheumatology, Department of Internal Medicine, University of Michigan Medical Schoolgrid.471406.0, Ann Arbor, Michigan, USA., Vendrov KC; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical Schoolgrid.471406.0, Ann Arbor, Michigan, USA., Standke AK; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical Schoolgrid.471406.0, Ann Arbor, Michigan, USA., Bergin IL; The Unit for Laboratory Animal Medicine, University of Michigan Medical Schoolgrid.471406.0, Ann Arbor, Michigan, USA., Schloss PD; Department of Microbiology & Immunology, University of Michigan Medical Schoolgrid.471406.0, Ann Arbor, Michigan, USA., Young VB; Department of Microbiology & Immunology, University of Michigan Medical Schoolgrid.471406.0, Ann Arbor, Michigan, USA.; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical Schoolgrid.471406.0, Ann Arbor, Michigan, USA. |
| Abstrakt: |
Susceptibility to Clostridioides difficile infection (CDI) typically follows the administration of antibiotics. Patients with inflammatory bowel disease (IBD) have increased incidence of CDI, even in the absence of antibiotic treatment. However, the mechanisms underlying this susceptibility are not well understood. To explore the intersection between CDI and IBD, we recently described a mouse model where colitis triggered by the murine gut bacterium, Helicobacter hepaticus, in IL-10 -/- mice led to susceptibility to C. difficile colonization without antibiotic administration. The current work disentangles the relative contributions of inflammation and gut microbiota in colonization resistance to C. difficile in this model. We show that inflammation drives changes in microbiota composition, which leads to CDI susceptibility. Decreasing inflammation with an anti-p40 monoclonal antibody promotes a shift of the microbiota back toward a colonization-resistant state. Transferring microbiota from susceptible and resistant mice to germfree animals transfers the susceptibility phenotype, supporting the primacy of the microbiota in colonization resistance. These findings shine light on the complex interactions between the host, microbiota, and C. difficile in the context of intestinal inflammation, and may form a basis for the development of strategies to prevent or treat CDI in IBD patients. IMPORTANCE Patients with inflammatory bowel disease (IBD) have an increased risk of developing C. difficile infection (CDI), even in the absence of antibiotic treatment. Yet, mechanisms regulating C. difficile colonization in IBD patients remain unclear. Here, we use an antibiotic-independent mouse model to demonstrate that intestinal inflammation alters microbiota composition to permit C. difficile colonization in mice with colitis. Notably, treating inflammation with an anti-p40 monoclonal antibody, a clinically relevant IBD therapeutic, restores microbiota-mediated colonization resistance to the pathogen. Through microbiota transfer experiments in germfree mice, we confirm that the microbiota shaped in the setting of IBD is the primary driver of susceptibility to C. diffiicile colonization. Collectively, our findings provide insight into CDI pathogenesis in the context of intestinal inflammation, which may inform methods to manage infection in IBD patients. More broadly, this work advances our understanding of mechanisms by which the host-microbiota interface modulates colonization resistance to C. difficile. |
